Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/1999
12/22/1999CN1047534C Scar-eliminating scald ointment
12/22/1999CN1047527C Chinese herb medicine instant granule for preventing and curing cardiovascular and cerebrovascular diseases
12/22/1999CN1047522C Method for refining aqueous extract of traditional Chinese medicine
12/22/1999CN1047518C Method of preparing oral pharmaceutical compositions
12/21/1999US6005039 Composite pressure sensitive hydrophilic adhesive and method of preparing the same
12/21/1999US6005020 Bioresorbable compositions for implantable prostheses
12/21/1999US6005005 Liquid pharmaceutical composition for oral use containing 2-(4-isobutylphenyl) propionic acid
12/21/1999US6005001 Pharmaceutical composition
12/21/1999US6004996 Tetrahydrolipstatin containing compositions
12/21/1999US6004973 Pharmaceutical compositions comprising rafamycin coprecipitates
12/21/1999US6004968 Viricides; free of ethylenediaminetetraacetic acid and ethanol; preservative efficacy
12/21/1999US6004949 Aqueous composition containing cromoglycic acid
12/21/1999US6004925 Polypeptide anticholesterol agents; cardiovascular disorders, restenosis, atherosclerosis
12/21/1999US6004763 Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
12/21/1999US6004585 Granular composition of a triazine compound
12/21/1999US6004582 For immediate delivery of a first active agent followed by a monitored, continuous, controlled and/or retarded delivery of a second active agent which is the same or different as the first active agent; time-release agents
12/21/1999US6004581 Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
12/21/1999US6004580 Comprising hydrophilic component, lipophilic component, surfactant, drug; drug immobilized in microemulsion-based gel
12/21/1999US6004579 Aging inhibition; wound healing agent; preserving organs; treating dermatological conditions such as wrinkling, sagging, baldness, psoriasis
12/21/1999US6004578 For enhancing the percutaneous absorption of drugs when administered to a body surface or membrane
12/21/1999US6004577 Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
12/21/1999US6004575 Use of (meth) acrylic acid/maleic acid copolymers for improving mucosal permeability
12/21/1999US6004574 For administration of medically useful polypeptides, for administering polypeptides through inhalation
12/21/1999US6004573 Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
12/21/1999US6004566 Bioactive drug or cosmetic substance presented in the form of submicron oil spheres alone, or drugs or cosmetic substances in a combination with the oil spheres in an aqueous suspension or emulsion
12/21/1999US6004551 Lactobacillus, skim milk, lactobacillus growth factor (lgf) and lactobacillus compositions which adhere to biomaterials, intestinal, vaginal and uroepithelial cells, to resist the action of certain anti-microbial agents
12/21/1999US6004549 Crystalline protein controlled release compositions
12/21/1999US6004537 Inhaler comprising container of pressurized aerosol solution comprising budesonide, formoterol, fluoroalkane propellant, cosolvent present in amount to dissolve or solubilize mixture
12/21/1999US6004534 Polymerized liposomes which have been modified, preferably on their surface, to contain molecule or ligand which targets specific site
12/21/1999US6004299 Injection vessel and solution-enclosed injection vessel in use thereof
12/21/1999CA2197075C Method of gene therapy using dna vectors without selection marker gene
12/21/1999CA2148311C Lipid vesicles, their process of production and their applications
12/21/1999CA2147272C Convertible microemulsion formulations
12/21/1999CA2126441C Microcrystalline cellulose spheronization composition
12/21/1999CA2124425C Pharmaceutical tablets releasing the active substance after a definite period of time
12/21/1999CA2082951C Pulmonary administration of granulocyte colony stimulating factor
12/21/1999CA2001325C Stabile parenteral solution of 2-phenyl-1,2-benzisoselenazol-3(2h)-one and process for producing the same
12/16/1999WO1999065136A1 Chuck apparatus for clamping a planar substrate in an electrostatic coating method
12/16/1999WO1999064615A1 Formulations for electroporation
12/16/1999WO1999064598A2 Novel insulin analogs with enhanced zinc binding
12/16/1999WO1999064580A1 Microneedle devices and methods of manufacture and use thereof
12/16/1999WO1999064465A1 Diluting and disintegrating composition, method for obtaining same and use thereof
12/16/1999WO1999064441A1 Method for preparing virus-safe pharmaceutical compositions
12/16/1999WO1999064393A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application
12/16/1999WO1999064094A1 Methods of delivering aerosolized polynucleotides to the respiratory tract
12/16/1999WO1999064082A1 Plaster containing an active agent
12/16/1999WO1999064059A2 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
12/16/1999WO1999064050A1 Novel potassium channel drugs and their uses
12/16/1999WO1999064027A1 Extracts of hypericum perforatum and formulations containing them
12/16/1999WO1999064026A1 A process of powder for bath from natural plants
12/16/1999WO1999064014A1 Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma
12/16/1999WO1999063997A1 Use of clonidine for treatment of addictions, epilepsy, sleep disorders, eating disorders and migraines
12/16/1999WO1999063986A1 Formulations for the treatment of gastro-oesophageal reflux
12/16/1999WO1999063972A1 Pharmaceutical product and methods and apparatus for making same
12/16/1999WO1999063971A1 Micro-osmotic controlled drug delivery systems
12/16/1999WO1999063970A1 Delavirdine tablet formulation
12/16/1999WO1999063969A1 Stabilized thyroxine medications
12/16/1999WO1999063968A1 Aqueous preparations containing hardly soluble drug
12/16/1999WO1999063967A1 Enhanced intra vaginal devices
12/16/1999WO1999063951A1 Gel cosmetic compositions
12/16/1999WO1999063828A1 Broad specificity dna damage endonuclease
12/16/1999WO1999055286A9 Drug-containing transdermal patches, plastisols and adhesives
12/16/1999DE19826592A1 Verfahren zur Herstellung eines aus einzelnen Schichten bestehenden Laminats A process for producing a laminate comprising individual layers
12/16/1999DE19826503A1 Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Chitosan und Phospholipiden Cosmetic and dermatological preparations containing chitosan and phospholipids
12/16/1999DE19826213A1 Neue Antiestrogene, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New antiestrogens, processes for their preparation and their pharmaceutical use
12/16/1999DE19826118A1 Wasserhaltige kosmetische oder pharmazeutische Stifte Hydrous cosmetic or pharmaceutical sticks
12/16/1999DE19825856A1 New topical formulation which includes active agent as liquid lipid nanoparticles in an oil-in-water emulsion
12/16/1999CA2334780A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application
12/16/1999CA2334625A1 Extracts of hypericum perforatum and formulations containing them
12/16/1999CA2334531A1 Gel cosmetic compositions
12/16/1999CA2334296A1 Enhanced intra vaginal devices
12/16/1999CA2333657A1 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
12/16/1999CA2333116A1 Chuck apparatus for clamping a planar substrate in an electrostatic coating method
12/16/1999CA2333107A1 Pharmaceutical product and methods and apparatus for making same
12/16/1999CA2330211A1 Formulations for electroporation
12/16/1999CA2318745A1 Novel potassium channel drugs and their uses
12/16/1999CA2301042A1 Micro-osmotic controlled drug delivery systems
12/15/1999EP0964000A1 Excipient and disintegrant composition, process for obtaining the same and its use
12/15/1999EP0963486A1 Composition containing humidity regulators, for tissue products
12/15/1999EP0963202A1 Formulations and methods for providing prolonged local anesthesia
12/15/1999EP0963198A1 ANTI-PARASITIC ACTION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) AND FORMULATIONS THAT PROLONG ITS ACTIVITY IN THE SKIN
12/15/1999EP0963196A2 Hyaluronic drug delivery system
12/15/1999EP0963161A1 Sugar-free dragee chewing sweets
12/15/1999EP0806894A4 Micellar nanoparticles
12/15/1999EP0805676B1 Pharmaceutical compositions in the form of slow release tablets based on high molecular weight polysaccharide granules
12/15/1999EP0701704B1 Material to be worn on the eyeball
12/15/1999EP0685457B1 Glycerol derivative, device and pharmaceutical composition
12/15/1999EP0650354B1 Solid and liquid solutions of drugs which are not readily soluble in water
12/15/1999EP0648106B1 Use of a vinyl lactam derived terpolymer as foaming agent in aerosol foam-forming compositions, and composition thereby obtained
12/15/1999EP0587840B1 Bioartificial endocrine device
12/15/1999EP0414730B1 Chemical Compounds and pharmaceutical compositions capable of releasing a drug
12/15/1999CN2353377Y Glossy-ganoderm instant powder packed in bag
12/15/1999CN1238700A Improvents in or relating to diagnostic/therapeutic agents
12/15/1999CN1238699A Improvements in or relating to contrast agents
12/15/1999CN1238697A Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype
12/15/1999CN1238695A Topical composition for preventing or treating bacterial skin infections
12/15/1999CN1238691A Liquid alendronate preparation
12/15/1999CN1238690A Improved pharmaceutical compositions
12/15/1999CN1238687A An oil composition of dihydropolyprenols
12/15/1999CN1238211A Yexiazhu tablet for treating hepatism